SGLT2 inhibitor empagliflozin could be a new treatment for children with type 2 diabetes: lancet

Published Date: 04 Mar 2023

United States: Empagliflozin could be a new treatment option for children and adolescents with type 2 diabetes, with phase 3 clinical trials showing...

Read Full News

Latest News

Obesity Subtypes Predict Poor Physical Function in Knee OA

Obesity and low muscle mass and/or cardiometabolic comorbidities impede physical functioning more than obesity alone in individuals with or at risk for knee osteoarthritis.

Promising Revolution Medicines Pancreatic Cancer Drug Has High Rate Of Mostly Manageable Side Effects

An experimental drug from Revolution Medicines that nearly doubled survival time for patients with advanced pancreas cancer in clinical trials comes with a high rate of...

Primary Care Slow to Adopt Alzheimer’s Blood Tests

Primary care clinicians with higher diagnostic confidence are adopting emerging blood-based Alzheimer’s disease tests, raising questions about training, access, and appropriate use.

Stress, BMI Linked to Earlier Puberty in Girls

Higher levels of non-estrogen hormones, along with stress and elevated BMI, are linked to earlier breast development in girls.

Bariatric Surgery Linked to Higher Nutrient Deficiency Risk

Metabolic bariatric surgery is tied to higher risks for multiple micronutrient deficiencies and metabolic complications than GLP-1 receptor agonist therapy.

Novo Nordisk Weight-loss Pill Powers Profit Beat in Race to Catch Eli Lilly

Novo Nordisk beat first-quarter profit forecasts and nudged up its full-year outlook on Wednesday, helped by stronger-than-expected sales of its new weight-loss pill in the...

Todays Updates

T-DXd Reduces Residual Disease in Early Breast Cancer

Neoadjuvant trastuzumab deruxtecan combination therapy reduces the residual cancer burden in high-risk early breast cancer, even if a pathologic complete response is not achieved, shows analysis.

Todays Updates

T-DXd Reduces Residual Disease in Early Breast Cancer

Neoadjuvant trastuzumab deruxtecan combination therapy reduces the residual cancer burden in high-risk early breast cancer, even if a pathologic complete response is not achieved, shows analysis.

Latest News

Obesity and low muscle mass and/or cardiometabolic comorbidities impede physical functioning more than obesity alone in individuals with or at risk for knee osteoarthritis.

An experimental drug from Revolution Medicines that nearly doubled survival time for patients with advanced pancreas cancer in clinical trials comes with a high rate of...

Primary care clinicians with higher diagnostic confidence are adopting emerging blood-based Alzheimer’s disease tests, raising questions about training, access, and appropriate use.

Higher levels of non-estrogen hormones, along with stress and elevated BMI, are linked to earlier breast development in girls.

Metabolic bariatric surgery is tied to higher risks for multiple micronutrient deficiencies and metabolic complications than GLP-1 receptor agonist therapy.

Novo Nordisk beat first-quarter profit forecasts and nudged up its full-year outlook on Wednesday, helped by stronger-than-expected sales of its new weight-loss pill in the...

News All Time

Constipation Linked to Greater Weight Loss on Semaglutide

Patients on semaglutide who experienced constipation had greater weight loss than those without constipation, and genes could be at play.

Capecitabine Extends PFS in Oesophagogastric Cancer

Maintenance therapy with capecitabine prolongs progression-free survival in patients with advanced oesophagogastric adenocarcinoma after first-line chemotherapy.

GLP-1 Drugs May Modestly Raise Optic Neuropathy Risk in T2D

GLP-1 therapy is linked to a modestly increased risk for nonarteritic anterior ischemic optic neuropathy compared with SGLT2 inhibitors in veterans with type 2 diabetes.

Postop Anorectal Morbidity Notable After Bariatric Surgery

Patients undergoing bariatric surgery experience high rates of new-onset benign anal disorders, with constipation more common after sleeve gastrectomy and diarrhea after gastric bypass.

Too Much, Too Little Exercise Tied to Higher Risk for OA

The fact that upper and lower limits of physical activity are linked to osteoarthritis isn’t surprising, but messaging for patients might take into account the type of physical activity they’re doing.

Early Knee OA Lifestyle Program Fails to Stop Progression

Despite requiring substantial resources, lifestyle programs are unlikely to be successful without including a strong behavioral change component, one commenter noted.

Weight-loss Revolution Sparks New Appetite for Aesthetics Firms

Aesthetic firms are betting that a growing pool of patients experiencing loose skin and facial volume loss from GLP-1 obesity drugs will fuel a new wave of demand, as the...

Gastric Bypass Leads to Diabetes Remission

Laparoscopic one anastomosis gastric bypass achieves sustained diabetes remission in most patients with type 2 diabetes and obesity over 10 years of follow-up.

Biomarkers May Guide Tailored Interventions in Obesity

Nutritional and metabolic biomarkers may aid in the early detection of obesity risk, guide precise interventions, and support tailored diets to improve metabolic health.

Gastric Ring Add-On May Aid Weight Loss After Surgery

A ring-augmented one anastomosis gastric bypass achieves greater weight loss than standard surgery in patients with recurrent weight gain or suboptimal outcomes after sleeve gastrectomy.

Oral Acromegaly Drug Performing Well in First Few Patients

Initial real-world results of patients receiving paltusotine suggest reduced symptoms and good tolerability, while a phase 3 trial finds no interaction with levothyroxine.

MASLD Risk May Be Higher in Men Who Eat More Red Meat

Red meat intake showed no overall association with MASLD risk, but higher daily consumption (75-90 g) was linked to increased risk in men.

Childhood Trauma Tied to Gestational Diabetes Risk

Women with prior adverse childhood experiences may face a higher risk for gestational diabetes, with the risk rising with each additional adverse experience, a meta-analysis of 11 studies shows.

Food Insecurity and Poverty May Raise MASLD Risk in US

People who do not have enough food to eat or who live below the poverty level are more likely to develop MASLD, and this risk is higher in non-Hispanic White individuals.

FDA Proposes End to Mass GLP-1 Compounding

The agency appears to leave a loophole for patient-specific formulations.

‘Cyborg’ Islet Cells and Potential New Diabetes Therapies

Researchers combined electronic sensors with human islet cells to create living ‘cyborg’ organoids transmitting troves of previously unseen data on islet cell function.

Recommended News For You

Sub-Q Ketamine is Safe and Very Effective for Severe Depression.

The majority of cancer medications that receive expedited approval end up failing confirmatory trials.

Treatment of Smoldering Myeloma Cuts Progression Rate in Half

An FDA panel supports the use of CAR T-cell therapy earlier in the treatment of multiple myeloma.

Weight-Based and Fixed-Dose Pembrolizumab Compared in NSCLC

Chris Hoy reveals that he has terminal cancer?here's how to spot early signs of prostate cancer

The acceptance of innovative hormonal therapy for advanced prostate cancer is racialized.

Recommended Articles For You

Cancer-Keeper Genes: Novel Therapeutic Targets for Disrupting Tumor Maintenance 

The Precision Revolution: Bispecific Antibodies and Antibody-Drug Conjugates Reshaping the Oncology Landscape 

Navigating the Stages of Thyroid Cancer: A Guide for Patients 

Unexplained Weight Loss: Revealing Occult Cancers and Paraneoplastic Syndromes 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

3D virtual staining technology enables non-invasive observation of cancer tissue

2.

Risk-Benefit Analysis of CAR-T Therapies for Myeloma is Muddy by Early Death Risk.

3.

BMI is linked to heart damage from chemotherapy in breast cancer patients.

4.

New Gene Therapy Nears EU Nod for Bladder Cancer

5.

Advanced Solid Tumors May Benefit from Investigative Immunotherapy Combo.

1.

Future of Chemotherapy: New Advances, Treatments & Survival Rates Transforming Cancer Care

2.

Case Study: Combining Targeted Therapy with Immunotherapy for Metastatic Melanoma

3.

The Importance of Corrected Calcium Levels in Managing Health Conditions 

4.

The Power of Salt Tablets: Unlocking Health Benefits Beyond Sodium

5.

Radiation Oncology: Integrating AI, Theranostics, and Adaptive Therapies for Personalized Cancer Care

1.

International Lung Cancer Congress®

2.

Genito-Urinary Oncology Summit 2026

3.

Future NRG Oncology Meeting

4.

ISMB 2026 (Intelligent Systems for Molecular Biology)

5.

Annual International Congress on the Future of Breast Cancer East

1.

Current Scenario of Cancer- Q&A Session to Close the Gap Part II

2.

Newer Immunotherapies for Myeloma- A Comprehensive Overview

3.

Pazopanib: A Game-Changer in Managing Advanced Renal Cell Carcinoma - Part IV

4.

Treatment Sequencing Strategies in ALK + NSCLC Patients with CNS Diseases

5.

Revolutionizing Treatment of ALK Rearranged NSCLC with Lorlatinib - Part III

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot